Cerebyx (fosphenytoin sodium)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
PRECAUTIONS
General: (phenytoin associated)
Plasma concentrations of phenytoin sustained above the optimal range may...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Phenytoin